83 related articles for article (PubMed ID: 28468052)
1. [Advances of FOXC1 transcription factor in cancer].
Zhang Y; Lai MD
Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):362-365. PubMed ID: 28468052
[No Abstract] [Full Text] [Related]
2. FOXC1: an emerging marker and therapeutic target for cancer.
Han B; Bhowmick N; Qu Y; Chung S; Giuliano AE; Cui X
Oncogene; 2017 Jul; 36(28):3957-3963. PubMed ID: 28288141
[TBL] [Abstract][Full Text] [Related]
3. The role and the potential regulatory pathways of high expression of forkhead box C1 in promoting tumor growth and metastasis of basal-like breast cancer.
Zuo HD; Wu Yao W
J BUON; 2016; 21(4):818-825. PubMed ID: 27685901
[TBL] [Abstract][Full Text] [Related]
4. FOXC1 promotes melanoma by activating MST1R/PI3K/AKT.
Wang J; Li L; Liu S; Zhao Y; Wang L; Du G
Oncotarget; 2016 Dec; 7(51):84375-84387. PubMed ID: 27533251
[TBL] [Abstract][Full Text] [Related]
5. FOXC1 overexpression is a marker of poor response to anthracycline-based adjuvant chemotherapy in sporadic triple-negative breast cancer.
Xu YL; Yao R; Li J; Zhou YD; Mao F; Pan B; Sun Q
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1205-1213. PubMed ID: 28493031
[TBL] [Abstract][Full Text] [Related]
6. FOXC1 Regulates FGFR1 Isoform Switching to Promote Invasion Following TGFβ-Induced EMT.
Hopkins A; Coatham ML; Berry FB
Mol Cancer Res; 2017 Oct; 15(10):1341-1353. PubMed ID: 28684636
[TBL] [Abstract][Full Text] [Related]
7. SnapShot: forkhead transcription factors I.
Tuteja G; Kaestner KH
Cell; 2007 Sep; 130(6):1160. PubMed ID: 17889656
[No Abstract] [Full Text] [Related]
8. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
[TBL] [Abstract][Full Text] [Related]
9. Forkhead box C1 promoter upstream transcript, a novel long non-coding RNA, regulates proliferation and migration in basal-like breast cancer.
Liu J; Shen L; Yao J; Li Y; Wang Y; Chen H; Geng P
Mol Med Rep; 2015 Apr; 11(4):3155-9. PubMed ID: 25516208
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-374c-5p regulates the invasion and migration of cervical cancer by acting on the Foxc1/snail pathway.
Huang Y; Huang H; Li M; Zhang X; Liu Y; Wang Y
Biomed Pharmacother; 2017 Oct; 94():1038-1047. PubMed ID: 28810526
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1.
Chung TK; Lau TS; Cheung TH; Yim SF; Lo KW; Siu NS; Chan LK; Yu MY; Kwong J; Doran G; Barroilhet LM; Ng AS; Wong RR; Wang VW; Mok SC; Smith DI; Berkowitz RS; Wong YF
Int J Cancer; 2012 Mar; 130(5):1036-45. PubMed ID: 21400511
[TBL] [Abstract][Full Text] [Related]
13. Comment on "cutting edge: epigenetic regulation of Foxp3 defines a stable population of CD4+ regulatory T cells in tumors from mice and humans".
Huehn J; Floess S; Ohkura N; Sakaguchi S
J Immunol; 2015 Apr; 194(8):3533. PubMed ID: 25848068
[No Abstract] [Full Text] [Related]
14. miR-4792 inhibits epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma by targeting FOXC1.
Li Y; Chen X
Biochem Biophys Res Commun; 2015 Dec; 468(4):863-9. PubMed ID: 26585487
[TBL] [Abstract][Full Text] [Related]
15. Response to comment on "cutting edge: epigenetic regulation of Foxp3 defines a stable population of CD4+ regulatory T cells in tumors from mice and humans".
Waight JD; Hofmeister R; Wilson NS
J Immunol; 2015 Apr; 194(8):3533-4. PubMed ID: 25848069
[No Abstract] [Full Text] [Related]
16. Research progress on the regulation of tumor initiation and development by the forkhead box Q1 gene.
Tang H; Zhang J; Guo Q
J Cancer Res Ther; 2018 Jan; 14(1):6-11. PubMed ID: 29516951
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay.
Jensen TW; Ray T; Wang J; Li X; Naritoku WY; Han B; Bellafiore F; Bagaria SP; Qu A; Cui X; Taylor CR; Ray PS
J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26041837
[TBL] [Abstract][Full Text] [Related]
18. FGF19 is a target for FOXC1 regulation in ciliary body-derived cells.
Tamimi Y; Skarie JM; Footz T; Berry FB; Link BA; Walter MA
Hum Mol Genet; 2006 Nov; 15(21):3229-40. PubMed ID: 17000708
[TBL] [Abstract][Full Text] [Related]
19. miR-133 inhibits pituitary tumor cell migration and invasion via down-regulating FOXC1 expression.
Wang DS; Zhang HQ; Zhang B; Yuan ZB; Yu ZK; Yang T; Zhang SQ; Liu Y; Jia XX
Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050992
[TBL] [Abstract][Full Text] [Related]
20. Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer.
Chung S; Jin Y; Han B; Qu Y; Gao B; Giuliano AE; Cui X
Cell Commun Signal; 2017 Jun; 15(1):22. PubMed ID: 28629477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
